Mark G Currie's Net Worth
$15.2 Million
Who is Mark G Currie?
Mark G Currie has an estimated net worth of $15.2 Million. This is based on reported shares across multiple companies, which include IRONWOOD PHARMACEUTICALS INC, and Cyclerion Therapeutics, Inc..
SEC CIK
Mark G Currie's CIK is 0001478244
Past Insider Trading and Trends
2019 was Mark G Currie's most active year for acquiring shares with 26 total transactions. Mark G Currie's most active month to acquire stocks was the month of March. 2018 was Mark G Currie's most active year for disposing of shares, totalling 26 transactions. Mark G Currie's most active month to dispose stocks was the month of January. 2019 saw Mark G Currie paying a total of $4,000,284.67 for 2,857,886 shares, this is the most they've acquired in one year. In 2019 Mark G Currie cashed out on 1,302,245 shares for a total of $3,839,794.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $4.51
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.47% | 24.31K |
—
|
—
| 568.42K |
Jun 18
| |||
Form 4
| +4.28% | 22.35K |
—
|
—
| 544.11K |
Jun 20
| |||
Form 4
| -11.83% | -70.00K |
$11.78 | -$824,600.00 | 521.76K |
Aug 11
| |||
Form 4
|
—
|
0
|
$11.83 | -$68,537.88 | 591.76K |
Scheduled
|
Jun 7
| ||
Form 4
| +3.78% | 21.57K |
—
|
—
| 591.76K |
Jun 1
| |||
Form 4
| -3.97% | -23.57K |
$11.59 | -$273,187.89 | 570.19K |
Scheduled
|
Jun 14
| ||
Form 4
| +3.99% | 22.77K |
—
|
—
| 593.76K |
Jun 2
| |||
Form 4
| +3.95% | 21.72K |
—
|
—
| 570.99K |
Jun 3
| |||
Form 4
|
—
|
0
|
$10.86 | -$208,200.00 | 549.27K |
Scheduled
|
Jan 23
| ||
Form 4
|
—
|
0
|
$11.41 | -$24,708.64 | 549.27K |
Scheduled
|
Jan 16
| ||
Form 4
| -0.42% | -2.34K |
—
|
—
| 549.27K |
Dec 16 - Dec 17
| |||
Form 4
| +4.29% | 22.71K |
—
|
—
| 551.61K |
May 29
| |||
Form 4
| -0.76% | -4.05K |
$10.53 | -$42,699.15 | 528.9K |
Scheduled
|
May 10
| ||
Form 4
| +0.85% | 4.48K |
—
|
—
| 532.96K |
Apr 1
| |||
Form 4
| -34.23% | -275.00K |
$13.26 | -$3,647,820.00 | 528.48K |
Mar 7 - Mar 8
| |||
Form 4
| -0.20% | -1.64K |
$14.31 | -$23,525.77 | 803.48K |
Scheduled
|
Feb 20 - Feb 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
| 805.12K |
Dec 31
| |||
Form 4
|
—
|
0
|
$14.33 | -$1,624,650.48 | 30.12K |
Scheduled
|
Oct 4 - Oct 5
| ||
Form 4
|
—
|
0
|
$11.67 | -$873,567.06 | 775K |
Scheduled
|
Aug 24
| ||
Form 4
|
—
|
0
|
$11.70 | -$1,754,932.94 | 775K |
Scheduled
|
Aug 22 - Aug 23
| ||
Form 4
| +66.21% | 12K |
—
|
—
| 30.12K |
Jul 31
| |||
Form 4
| -8.27% | -1.63K |
$14.66 | -$23,954.44 | 18.12K |
Scheduled
|
Feb 21
| ||
Form 4
|
—
|
0
|
$9.61 | -$701,400.00 | 775K |
Scheduled
|
Jan 24
| ||
Form 4
| -7.06% | -1.50K |
—
|
—
| 19.76K |
Dec 7
| |||
Form 4
|
—
|
0
|
$10.41 | -$798,000.00 | 775K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| -7.81% | -1.80K |
$16.94 | -$30,492.00 | 21.26K |
Scheduled
|
Feb 22
| ||
Form 4
| +7.79% | 55.99K |
$2.94 | $164,601.78 | 775K |
Jan 18
| |||
Form 4
| +4.97% | 34.01K |
$2.94 | $99,998.22 | 719.01K |
Jan 6
| |||
Form 4
| -9.78% | -2.50K |
—
|
—
| 23.06K |
Dec 7
| |||
Form 4
| +77.92% | 300K |
$2.94 | $882,000.00 | 685K |
Oct 31
| |||
Form 4
| +2.91% | 10.9K |
$6.21 | -$1,377,999.12 | 385K |
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -0.54% | -2.15K |
$5.04 | -$1,063,809.00 | 399.66K |
Scheduled
|
Feb 24
| ||
Form 4
| +20.68% | 64.1K |
$1.56 | $99,999.12 | 374.1K |
Jan 4
| |||
Form 4
| +518.00% | 21.88K |
—
|
—
| 26.1K |
Mar 16
| |||
Form 4
|
—
|
0
|
$8.14 | -$376,750.00 | 310K |
Scheduled
|
Feb 19
| ||
Form 4
|
—
|
0
|
$7.12 | -$260,600.00 | 310K |
Scheduled
|
Nov 13
| ||
Form 4
|
—
|
0
|
$7.27 | -$333,250.00 | 310K |
Scheduled
|
May 22
| ||
Form 4
|
—
|
0
|
$6.14 | -$276,750.00 | 310K |
Scheduled
|
Apr 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
$7.52 | -$207,450.00 | 310K |
Scheduled
|
Feb 18
| ||
Form 4
|
—
|
0
|
$7.49 | -$275,600.00 | 310K |
Scheduled
|
Jan 23
| ||
Form 4
| +47.62% | 100K |
$0.60 | $60,000.00 | 310K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
$7.89 | -$291,400.00 | 210K |
Scheduled
|
Apr 21
| ||
Form 4
|
—
|
0
|
$7.80 | -$217,972.80 | 210K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$7.80 | -$358,027.20 | 210K |
Scheduled
|
Apr 11 - Apr 13
| ||
Form 4
|
—
|
0
|
$6.91 | -$504,400.00 | 210K |
Scheduled
|
Mar 21
| ||
Form 4
|
—
|
0
|
$6.56 | -$91,957.11 | 210K |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
$6.55 | -$27,120.10 | 210K |
Scheduled
|
Feb 25 - Feb 28
| ||
Form 4
|
—
|
0
|
$6.25 | -$338,594.94 | 210K |
Scheduled
|
Feb 22 - Feb 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cyclerion Therapeutics, Inc. (CYCN) Snapshot price: $3.18
President and CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.40% | -20.11K |
$3.01 | -$60,522.07 | 251.65K |
Dec 28
| |||
Form 4
| -15.54% | -50.00K |
$2.52 | -$125,750.00 | 271.75K |
Dec 27 - Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
∞
| 321.75K |
$14.81 | $4,000,284.67 | 321.75K |
Apr 1 - Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |